Forbes: The Pandemic Changed The Future Of Crispr - Here’s What Comes Next Says This Crispr CEO
It’s been a transformative year for synthetic biology and for the world. The COVID-19 pandemic exposed weaknesses in our global...
LogicInk partners with the 221b Foundation to develop instrument-free CRISPR diagnostic for COVID-19
Non-invasive, Saliva-based COVID-19 CRISPR Biosensor to Provide Clinical Performance Comparable to Benchmark Standard Tests without Need for Power or Instrumentation CAMBRIDGE, Mass....
New sunscreen stickers alert you when you need to reapply
LogicInk's Suncare Signals were featured in Input Magazine This isn’t the first product of its kind. A company called LogicInk sells...
T-Pain's School of Business on Fuse TV
T-Pain's School Of Business: Tech With A Higher Purpose (Our segment begins at 13:40 mark) T-Pain stopped by our lab and we took him behind the scenes...